An international clinical trial found that new drug aficamten boosts exercise capacity and quality of life for obstructive hypertrophic cardiomyopathy patients.
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024 wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Investigational drug shows promise in increasing oxygen uptake for patients with heart condition news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.